Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention
Authors
Keywords
-
Journal
CIRCULATION
Volume 140, Issue 3, Pages 240-261
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2019-05-22
DOI
10.1161/circulationaha.119.040167
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Racial Differences in Ischaemia/Bleeding Risk Trade-Off during Anti-Platelet Therapy: Individual Patient Level Landmark Meta-Analysis from Seven RCTs
- (2019) Jeehoon Kang et al. THROMBOSIS AND HAEMOSTASIS
- Impact of Baseline Thrombocytopenia on Bleeding and Mortality After Percutaneous Coronary Intervention
- (2018) Shinya Ito et al. AMERICAN JOURNAL OF CARDIOLOGY
- Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT). In collaboration with the French Society for Anesthesia and Intensive Care (SFAR)
- (2018) Anne Godier et al. Archives of Cardiovascular Diseases
- Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention
- (2018) Usman Baber et al. Circulation-Cardiovascular Interventions
- Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs
- (2018) Ingvar Bjarnason et al. GASTROENTEROLOGY
- Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score
- (2018) Sergio Raposeiras-Roubín et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Short-Term Versus Long-Term Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Elderly Patients
- (2018) Seung-Yul Lee et al. JACC-Cardiovascular Interventions
- A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery
- (2018) Roberta Rossini et al. JACC-Cardiovascular Interventions
- Cardiorenal Safety of OTC Analgesics
- (2018) William B. White et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- 6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial
- (2018) Joo-Yong Hahn et al. LANCET
- Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial
- (2018) Olivier Varenne et al. LANCET
- Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA
- (2018) S. Claiborne Johnston et al. NEW ENGLAND JOURNAL OF MEDICINE
- Manejo perioperatorio y periprocedimiento del tratamiento antitrombótico: documento de consenso de SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT y AEU
- (2018) David Vivas et al. REVISTA ESPANOLA DE CARDIOLOGIA
- 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
- (2018) William J. Powers et al. STROKE
- Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry
- (2018) Carme Guerrero et al. THROMBOSIS RESEARCH
- Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention
- (2018) Dominick J. Angiolillo et al. CIRCULATION
- Impact of Chronic Thrombocytopenia on In-Hospital Outcomes After Percutaneous Coronary Intervention
- (2018) Karam Ayoub et al. JACC-Cardiovascular Interventions
- Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
- (2018) Pascal Vranckx et al. LANCET
- The Association of Frailty With In-Hospital Bleeding Among Older Adults With Acute Myocardial Infarction
- (2018) John A. Dodson et al. JACC-Cardiovascular Interventions
- Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors
- (2017) Laura Pasea et al. EUROPEAN HEART JOURNAL
- The management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia: a clinical conundrum
- (2017) Cian P McCarthy et al. EUROPEAN HEART JOURNAL
- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
- (2017) Marco Valgimigli et al. EUROPEAN HEART JOURNAL
- Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment
- (2017) Minjong Lee et al. HEPATOLOGY
- Drug-coated versus bare-metal stents for elderly patients: A predefined sub-study of the LEADERS FREE trial
- (2017) Marie-Claude Morice et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- In-Hospital Outcomes of Percutaneous Coronary Intervention in America’s Safety Net
- (2017) Tushar Acharya et al. JACC-Cardiovascular Interventions
- Incidence and predictors of bleeding complications after percutaneous coronary intervention
- (2017) Yohei Numasawa et al. Journal of Cardiology
- Use of Antiplatelet Therapy/DAPT for Post-PCI Patients Undergoing Noncardiac Surgery
- (2017) Subhash Banerjee et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Trends in U.S. Cardiovascular Care
- (2017) Frederick A. Masoudi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial
- (2017) Francis K L Chan et al. LANCET
- Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial
- (2017) David E Kandzari et al. LANCET
- Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials
- (2017) Francesco Costa et al. LANCET
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
- (2017) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
- (2017) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of Brain Arteriovenous Malformations: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
- (2017) Colin P. Derdeyn et al. STROKE
- Trends in Bare-Metal Stent Use in the United States in Patients Aged ≥65 Years (from the CathPCI Registry)
- (2016) Jennifer A. Rymer et al. AMERICAN JOURNAL OF CARDIOLOGY
- Meta-Analysis of the Prognostic Impact of Anemia in Patients Undergoing Percutaneous Coronary Intervention
- (2016) Chun Shing Kwok et al. AMERICAN JOURNAL OF CARDIOLOGY
- Temporal Trends, Predictors, and Outcomes of In-Hospital Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention
- (2016) Nileshkumar J. Patel et al. AMERICAN JOURNAL OF CARDIOLOGY
- Percutaneous Coronary Intervention in Patients With End-Stage Liver Disease
- (2016) Vikas Singh et al. AMERICAN JOURNAL OF CARDIOLOGY
- Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?
- (2016) Sara Ariotti et al. JACC-Cardiovascular Interventions
- Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention
- (2016) Robert W. Yeh et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents
- (2016) Usman Baber et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
- (2016) Glenn N. Levine et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial
- (2016) Clemens von Birgelen et al. LANCET
- Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack
- (2016) S. Claiborne Johnston et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease
- (2016) Kaare H. Bønaa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
- (2016) C. Michael Gibson et al. NEW ENGLAND JOURNAL OF MEDICINE
- An international comparison of patients undergoing percutaneous coronary intervention: A collaborative study of the National Cardiovascular Data Registry (NCDR) and Japan Cardiovascular Database–Keio interhospital Cardiovascular Studies (JCD-KiCS)
- (2015) Shun Kohsaka et al. AMERICAN HEART JOURNAL
- Prevalence and Impact of High Platelet Reactivity in Chronic Kidney Disease: Results From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Registry
- (2015) U. Baber et al. Circulation-Cardiovascular Interventions
- Efficacy and Safety of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent: The EVOLVE II Randomized Trial
- (2015) D. J. Kereiakes et al. Circulation-Cardiovascular Interventions
- Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary
- (2015) Robert A. Byrne et al. EUROPEAN HEART JOURNAL
- Prevention and treatment of atherosclerosis in haemophilia - how to balance risk of bleeding with risk of ischaemic events
- (2015) Emmanuelle de Raucourt et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation
- (2015) Katrin A. Fiedler et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Zotarolimus-Eluting Versus Bare-Metal Stents in Uncertain Drug-Eluting Stent Candidates
- (2015) Marco Valgimigli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH
- (2015) S. Kaatz et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk
- (2015) Philip Urban et al. NEW ENGLAND JOURNAL OF MEDICINE
- The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease
- (2014) A. B. Federici et al. BLOOD
- Efficacy and Safety of Adjusted-Dose Prasugrel Compared With Clopidogrel in Japanese Patients With Acute Coronary Syndrome
- (2014) Shigeru Saito et al. CIRCULATION JOURNAL
- Management of Antiplatelet and Anticoagulant Therapy in Patients With Atrial Fibrillation in the Setting of Acute Coronary Syndromes or Percutaneous Coronary Interventions
- (2014) Davide Capodanno et al. Circulation-Cardiovascular Interventions
- 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management
- (2014) EUROPEAN HEART JOURNAL
- Risk of Upper Gastrointestinal Bleeding From Different Drug Combinations
- (2014) Gwen M.C. Masclee et al. GASTROENTEROLOGY
- Second-Generation Drug-Eluting Stent Implantation Followed by 6- Versus 12-Month Dual Antiplatelet Therapy
- (2014) Antonio Colombo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Randomized Comparison of Platinum Chromium-Based Everolimus-Eluting Stents Versus Cobalt Chromium-Based Zotarolimus-Eluting Stents in All-Comers Receiving Percutaneous Coronary Intervention
- (2014) Kyung Woo Park et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Role of cardiac catheterization and percutaneous coronary intervention in the preoperative assessment and management of patients before orthotopic liver transplantation
- (2014) Haripriya Maddur et al. LIVER TRANSPLANTATION
- Untreated brain arteriovenous malformation: Patient-level meta-analysis of hemorrhage predictors
- (2014) H. Kim et al. NEUROLOGY
- Aspirin in Patients Undergoing Noncardiac Surgery
- (2014) P.J. Devereaux et al. NEW ENGLAND JOURNAL OF MEDICINE
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
- (2014) Laura Mauri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
- (2014) Walter N. Kernan et al. STROKE
- Validated Contemporary Risk Model of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions: Insights From the National Cardiovascular Data Registry Cath‐PCI Registry
- (2014) Thomas T. Tsai et al. Journal of the American Heart Association
- Continuation of Low-Dose Aspirin Therapy in Peptic Ulcer Bleeding
- (2013) Joseph J.Y. Sung ANNALS OF INTERNAL MEDICINE
- Management of Antiplatelet Therapy in Patients With Coronary Artery Disease Requiring Cardiac and Noncardiac Surgery
- (2013) Davide Capodanno et al. CIRCULATION
- An Updated Bleeding Model to Predict the Risk of Post-Procedure Bleeding Among Patients Undergoing Percutaneous Coronary Intervention
- (2013) Sunil V. Rao et al. JACC-Cardiovascular Interventions
- Primary non-variceal upper gastrointestinal bleeding in NSAID and low-dose aspirin users: development and validation of risk scores for either medication in two large Dutch cohorts
- (2013) Nicolette L. de Groot et al. JOURNAL OF GASTROENTEROLOGY
- Population Trends in Percutaneous Coronary Intervention
- (2013) Marieke L. Fokkema et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial
- (2013) Willem JM Dewilde et al. LANCET
- Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study
- (2013) Roxana Mehran et al. LANCET
- Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial
- (2013) J P Mohr et al. LANCET
- Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
- (2013) Yongjun Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transfusion Strategies for Acute Upper Gastrointestinal Bleeding
- (2013) Càndid Villanueva et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Vorapaxar in Patients With Prior Ischemic Stroke
- (2013) David A. Morrow et al. STROKE
- Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting
- (2012) Marco Valgimigli et al. CIRCULATION
- Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and a History of Stroke or Transient Ischemic Attack
- (2012) Stefan K. James et al. CIRCULATION
- The Impact of Anemia on Long-Term Clinical Outcome in Patients Undergoing Revascularization With the Unrestricted Use of Drug-Eluting Stents
- (2012) Thomas Pilgrim et al. Circulation-Cardiovascular Interventions
- A New Strategy for Discontinuation of Dual Antiplatelet Therapy
- (2012) Byeong-Keuk Kim et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of Clopidogrel Added to Aspirin in Patients with Recent Lacunar Stroke
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary Stenting
- (2012) Jean-Philippe Collet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atherothrombosis in von Willebrand Disease: An Analysis of the Literature and Implications for Clinical Management
- (2012) Massimo Franchini et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: Analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial
- (2011) Diaa A. Hakim et al. AMERICAN HEART JOURNAL
- In-Hospital Major Bleeding During ST-Elevation and Non–ST-Elevation Myocardial Infarction Care: Derivation and Validation of a Model from the ACTION Registry®-GWTG™
- (2011) Robin Mathews et al. AMERICAN JOURNAL OF CARDIOLOGY
- Standardized Bleeding Definitions for Cardiovascular Clinical Trials
- (2011) Roxana Mehran et al. CIRCULATION
- Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents
- (2011) Hyeon-Cheol Gwon et al. CIRCULATION
- A New Era of Prospective Real-World Safety Evaluation
- (2011) Mitchell W. Krucoff et al. JACC-Cardiovascular Interventions
- The Academic Research Consortium Governance Charter
- (2011) Mitchell W. Krucoff et al. JACC-Cardiovascular Interventions
- Long-Term Impact of Chronic Kidney Disease in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
- (2011) Adam J. Saltzman et al. JACC-Cardiovascular Interventions
- Incidence, Prognostic Impact, and Influence of Antithrombotic Therapy on Access and Nonaccess Site Bleeding in Percutaneous Coronary Intervention
- (2011) Freek W.A. Verheugt et al. JACC-Cardiovascular Interventions
- Coronary Artery Stents and Antiplatelet Therapy in Patients With Cirrhosis
- (2011) Mark W. Russo et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting Coronary Stent
- (2011) Gregg W. Stone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clinical Evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries
- (2011) Alan C. Yeung et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention
- (2010) Philippe Gabriel Steg et al. CIRCULATION
- Incidence, Predictors, and Prognostic Implications of Hospitalization for Late Bleeding After Percutaneous Coronary Intervention for Patients Older Than 65 Years
- (2010) Dennis T. Ko et al. Circulation-Cardiovascular Interventions
- Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis
- (2010) G. Ducrocq et al. EUROPEAN HEART JOURNAL
- A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes
- (2010) Roxana Mehran et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial
- (2010) Shamir R Mehta et al. LANCET
- Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial
- (2010) Klaus Rasmussen et al. LANCET
- Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents
- (2010) Patrick W. Serruys et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guidelines for Prevention of NSAID-Related Ulcer Complications
- (2009) Frank L Lanza et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation
- (2009) Takeshi Kimura et al. CIRCULATION
- Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction
- (2009) Sumeet Subherwal et al. CIRCULATION
- Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial
- (2009) R. A. Byrne et al. EUROPEAN HEART JOURNAL
- Impact of Chronic Kidney Disease on Early (30-Day) and Late (1-Year) Outcomes of Patients With Acute Coronary Syndromes Treated With Alternative Antithrombotic Treatment Strategies
- (2009) Roxana Mehran et al. JACC-Cardiovascular Interventions
- In-Hospital and 1-Year Outcomes Among Percutaneous Coronary Intervention Patients With Chronic Kidney Disease in the Era of Drug-Eluting Stents
- (2009) Faisal Latif et al. JACC-Cardiovascular Interventions
- Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial
- (2009) Gilles Montalescot et al. LANCET
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients With Coronary Artery Disease
- (2008) Gregg W. Stone JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial
- (2008) Stephan Windecker et al. LANCET
- Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke
- (2008) Ralph L. Sacco et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
- (2007) Spencer B. King et al. CIRCULATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More